Preoperative Herceptin and Navelbine in Early Stage, HER-2 Positive Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Nov 2009
At a glance
- Drugs Trastuzumab (Primary) ; Vinorelbine (Primary) ; Cyclophosphamide; Doxorubicin; Paclitaxel
- Indications Breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Nov 2009 Planned end date changed from 1 May 2008 to 1 Apr 2010 as reported by ClinicalTrials.gov.
- 26 Nov 2005 New trial record.